Melendez-Torres, G. J.Armoiry, XavierCourt, RachelPatterson, JacobyKan, AlanAuguste, PeterMadan, JasonCounsell, CarlCiccarelli, OlgaClarke, Aileen2018-10-172018-10-172018-10-03Melendez-Torres, G J, Armoiry, X, Court, R, Patterson, J, Kan, A, Auguste, P, Madan, J, Counsell, C, Ciccarelli, O & Clarke, A 2018, 'Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis : systematic review and network meta-analysis of trials including recommended dosages', BMC Neurology, vol. 18, 162. https://doi.org/10.1186/s12883-018-1162-91471-2377RIS: urn:E9C520A36BFECC63274148314181CD8FRIS: Melendez-Torres2018ORCID: /0000-0001-6622-7839/work/164505693http://hdl.handle.net/2164/11266This work is part of a larger report commissioned by the NIHR HTA Programme as project number ID809. Aileen Clarke and G.J. Melendez-Torres are partly supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands at the University Hospitals Birmingham NHS Foundation Trust. The views expressed are those of the authors and not necessarily those of the NHS, NIHR, NICE or the Department of Health and Social Care.863759engmultiple sclerosisclinically isolated syndromebeta-interferonglatiramer acetatesystematic revieweconomic evaluationR MedicineNational Institute for Health Research (NIHR)RJournal article10.1186/s12883-018-1162-918